30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Scott Kathleen D.

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return -9% 8.2% 15.1%
Success rate 7% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Scott Kathleen D.'s trades of Dermata Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-16 2026-06-16
S Sale
38,783 +4.5%
413.73
US$2,883,722 		38,783 +4.5% 413.73 US$2,883,722
2025-08-22 2025-08-21
PlS Planned sale
91,199 -36.4%
320.48
US$3,450,509 		91,199 -36.4% 320.48 US$3,450,509
2025-08-21 2025-08-21
PrS Proposed sale
34,825
317.26
US$4,953,265 		34,825 317.26 US$4,953,265
2025-05-22 2025-05-20
S Sale
50,000 -87.1%
14.10
US$705,165 		50,000 -87.1% 14.10 US$705,165
2025-05-20 2025-05-20
PrS Proposed sale
50,000
14.10
US$705,000 		50,000 14.10 US$705,000
2024-10-17 2024-10-16
PlS Planned sale
12,500 -71.6%
16.00
US$200,000 		12,500 -71.6% 16.00 US$200,000
2024-10-16 2024-10-16
PrS Proposed sale
12,500
16.00
US$200,000 		12,500 16.00 US$200,000
2024-08-21 2024-08-20
PlS Planned sale
12,500 -48.6%
16.00
US$200,000 		12,500 -48.6% 16.00 US$200,000
2024-08-20 2024-08-20
PrS Proposed sale
12,500
16.00
US$200,000 		12,500 16.00 US$200,000
2022-12-01 2022-11-29
B Purchase
8,250 +inf%
6.24
US$51,506 		8,250 +inf% 6.24 US$51,506